Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference NEW YORK – September 26, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central…